HIV-positive patients in the United States face significant challenges associated with poor adherence to antiretroviral therapy (ART) and HIV-1 drug resistance, according to a study published in AIDS and Behavior.
HIV testing occurs at less than 1% of physician office and emergency department visits and at less than 3% of community health center visits.
Patients who are HIV-positive with a probable or proven severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection may not be at a greater risk for severe disease or death compared with patients who are HIV-negative,
Many sexually active men who have sex with men do not receive recommended prevention services and STD testing when receiving care for HIV infection.
Focused prevention and treatment of noncommunicable diseases may reduce the burden of multimorbidity in people living with HIV who have mood disorders and multimorbidity.
Researchers studied the average age of menopause, prevalence of early menopause and premature menopause, and correlates of menopause occurring at <45 years in women living with HIV.
Symtuza is a 4-drug combination of darunavir, an HIV-1 protease inhibitor; cobicistat, a CYP3A inhibitor; and emtricitabine and tenofovir alafenamide.
Most have regular doctor, but few have had conversations about same-sex sexual behaviors, HIV testing.
NIH-sponsored trial was being conducted in South Africa.
Integrase strand transfer inhibitors (INSTIs) are a generally well-tolerated class of antiretrovirals that have a higher antiviral potency compared with other classes of ART.
